
The Medical Journal of Australia, Journal Year: 2024, Volume and Issue: 221(8), P. 438 - 446
Published: Sept. 15, 2024
Abstract Introduction The 2024 Australian evidence‐based guideline for unexplained infertility provides clinicians with recommendations the optimal diagnostic workup infertile couples to establish diagnosis of and therapeutic approach treat diagnosed in health care setting. were adapted context from rigorous, comprehensive European Society Human Reproduction Embryology (ESHRE) 2023 Evidence‐based guideline: , using ADAPTE process have been approved by National Health Medical Research Council. Main includes 40 recommendations, 21 practice points three research addressing: definition — defining frequency intercourse, age, female male factor infertility; ovulation, ovarian reserve, tubal factor, uterine laparoscopy, cervical/vaginal additional testing systemic conditions; treatment expectant management, active treatment, mechanical‐surgical procedures, alternative approaches, quality life. Changes assessment management resulting This refines addresses basic procedures not considered previous guidelines on infertility. For consideration evidence quality, efficacy, safety and, setting, feasibility, acceptability, cost, implementation ultimately recommendation strength integrated across multidisciplinary expertise consumer perspectives adapting Grading Recommendations, Assessment, Development Evaluation (GRADE) framework, which had used past formulate recommendations. also included an established data integrity check ensure could be trusted guide practice. Practice added expanded consider No underpinned high evidence, most having low or very evidence. In this context, made including those context. full technical report are publicly available online can accessed at https://www.monash.edu/medicine/mchri/infertility supported extensive translation resources, free patient ASKFertility mobile application ( https://www.askfertility.org/ ).
Language: Английский